Clinical trials on patients are a slow and expensive process with zero repeatability so it makes sense to simulate the symptoms experienced. This is where VisSim is enabling ResMed to a quicker result.
By using VisSim to develop a ‘bench patient’, ResMed has been able to develop its own breathing simulators based on sophisticated physiological computer models, together with a library of VisSim-based ‘virtual patients’ with a variety of pathologies.
The VisSim based ‘bench patient’ has greatly accelerated equivalence testing of ResMed’s second-generation therapy device. The result was shorter clinical trials and reduced time-to-market.
ResMed sees its continuing use of VisSim as beneficial in simultaneously maximising quality, minimising development time and enhancing the customer experience through use of realistic product models.
To read this and other VisSim case studies, go to:
http://www.adeptscience.co.uk/download/dldcat/37/0/All/VisSim.html
The VisSim product range is supplied and supported by Adept Scientific in the UK, Ireland, Germany, Austria, Scandinavia and the Nordic countries.
Write a comment
No comments